The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial
Open accessPublished version of a preprint
Abstract
Background: Mesenchymal stem cell (MSC) infusion was reported to improve liver function in patients with decompensated liver cirrhosis (DLC); however, whether the medication can improve outcome of these patients is poorly understood. Methods: This prospective, open-labeled, randomized controlled study enrolled 219 patients with HBV-related DLC who were divided into control group ( n = 111) and umbilical cord-derived MSC (UC-MSC)-treated group ( n = 108), then all of them received a follow-up check from October 2010 to October 2017. The treated patients received three times of UC-MSC infusions at 4-week intervals plus conventional treatment that was only used for control group. The overall survival rate and HCC-free survival rate were calculated as primary endpoints and the liver function and adverse events associated with the medication were also evaluated. Results: During the follow-up check period from 13 to 75th months, there was a significantly higher overall survival rate in the treated group than the control group, while the difference of the hepatocellular carcinoma event-free survival rate between the treated and control groups was not observed during the 75-month follow-up. UC-MSC treatment markedly improved liver function, as indicated by the levels of serum albumin, prothrombin activity, cholinesterase, and total bilirubin during 48 weeks of follow-up. No significant side effects or treatment-related complications were observed in the UC-MSC group. Conclusions: Therapy of UC-MSC is not only well tolerated, but also significantly improves long-term survival rate, as well as the liver function in patients with HBV-related DLC. UC-MSC medication, therefore, might present a novel therapeutic approach for the disease. Graphic abstract:
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The most common side effect observed was fever, which could be subsided by regular antipyretics [287, 292, 300].”
From Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis/cirrhosis: focusing on mesenchymal stromal cells (2025) · cites this paper as [287]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared to the control group, the treated group had a significantly higher overall survival rate from 13 to 75 months and markedly improved liver functions, as evidenced by serum ALB, PTA, CHE, and TBIL levels during 48 weeks.”
From Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis/cirrhosis: focusing on mesenchymal stromal cells (2025) · cites this paper as [287]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mesenchymal stem cells in health and disease
Uccelli, A., Moretta, L., & Pistoia, V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2395 · Cited by 3,746
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Sundberg, B., Bernardo, M. E., Remberger, M., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60690-x · Cited by 2,695
Røsland, G. V., Svendsen, A., Torsvik, A., Sobala, E., McCormack, E., Immervoll, H., Mysliwietz, J., Tonn, J.-C., Goldbrunner, R., Lønning, P. E., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4630 · Cited by 644
Kharaziha, P., Hellström, P. M., Noorinayer, B., Farzaneh, F., Aghajani, K., Jafari, F., Telkabadi, M., Atashi, A., Honardoost, M., Zali, M. R., et al. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32832a1f6c · Cited by 492 · cited 1×
“In the clinical setting, several studies have shown that infusions of autologous BM-MSC can significantly improve liver function in patients with liver cirrhosis [6, 7].”
BackgroundTerai, S., Ishikawa, T., Omori, K., Aoyama, K., Marumoto, Y., Urata, Y., Yokoyama, Y., Uchida, K., Yamasaki, T., Fujii, Y., et al. (2006) · STEM CELLS · doi:10.1634/stemcells.2005-0542 · Cited by 491
Ramasamy, R., Lam, E. W.-F., Soeiro, I., Tisato, V, Bonnet, D., & Dazzi, F. (2007) · Leukemia · doi:10.1038/sj.leu.2404489 · Cited by 404
Shi, M., Zhang, Z., Xu, R., Lin, H., Fu, J., Zou, Z., Zhang, A., Shi, J., Chen, L., Lv, S., et al. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0034 · Cited by 374
Self-citationZhang, Z., Lin, H., Shi, M., Xu, R., Fu, J., Lv, J., Chen, L., Lv, S., Li, Y., Yu, S., et al. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.07024.x · Cited by 372 · cited 2×
“Our previous studies showed that UC-MSC infusion significantly improved liver function in patients with decompensated liver cirrhosis [12] and primary biliary cirrhosis [13] and increased the survival rates of patients with acute-on-chronic liver failure (ACLF) [14].”
BackgroundSelf-citationPeng, L., Xie, D.-Y., Lin, B.-L., Liu, J., Zhu, H.-P., Xie, C., Zheng, Y.-B., & Gao, Z.-L. (2011) · Hepatology · doi:10.1002/hep.24434 · Cited by 365
Cited by
Xu, X., Poulsen, K. L., Wu, L., Liu, S., Miyata, T., Song, Q., Wei, Q., Zhao, C., Lin, C., & Yang, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01119-3 · Cited by 359
Liver diseases: epidemiology, causes, trends and predictions
Gan, C., Yuan, Y., Shen, H., Gao, J., Kong, X., Che, Z., Guo, Y., Wang, H., Dong, E., & Xiao, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02072-z · Cited by 310
Zhang, Z., Shang, J., Yang, Q., Dai, Z., Liang, Y., Lai, C., Feng, T., Zhong, D., Zou, H., Ji, G., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01788-4 · Cited by 131
Mesenchymal Stem Cell-Derived Extracellular Vesicles in Liver Immunity and Therapy
Wu, R., Fan, X., Wang, Y., Shen, M., Zheng, Y., Zhao, S., & Yang, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.833878 · Cited by 142
Mesenchymal stromal cells in hepatic fibrosis/cirrhosis: from pathogenesis to treatment
Yang, X., Li, Q., Liu, W., Zong, C., Wei, L., Shi, Y., & Han, Z. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-00983-5 · Cited by 120
Advances and clinical challenges of mesenchymal stem cell therapy
Mei, R., Wan, Z., Yang, C., Shen, X., Wang, R., Zhang, H., Yang, R., Li, J., Song, Y., & Su, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1421854 · Cited by 101
Self-citationYu, S., Yu, S., Liu, H., Liao, N., & Liu, X. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03476-4 · Cited by 96
Self-citationStem cells for treatment of liver fibrosis/cirrhosis: clinical progress and therapeutic potential
Liu, P., Mao, Y., Xie, Y., Wei, J., & Yao, J. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03041-5 · Cited by 82
Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies
Di, X., Li, Y., Wei, J., Li, T., & Liao, B. (2024) · Advanced Science · doi:10.1002/advs.202410416 · Cited by 121
Self-citationLiu, Y., Dong, Y., Wu, X., Xu, X., & Niu, J. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02882-4 · Cited by 77
Lu, W., Qu, J., Yan, L., Tang, X., Wang, X., Ye, A., Zou, Z., Li, L., Ye, J., & Zhou, L. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03518-x · Cited by 49
Mesenchymal stem cells lineage and their role in disease development
Xu, Q., Hou, W., Zhao, B., Fan, P., Sheng, W., Wang, L., & Gao, J. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00967-9 · Cited by 58
Self-citationPharoun, J., Berro, J., Sobh, J., Abou-Younes, M.-M., Nasr, L., Majed, A., Khalil, A., Joseph, J., Stephan, & Faour, W. H. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176719 · Cited by 59
Therapeutic Effects of Mesenchymal Stromal Cells Require Mitochondrial Transfer and Quality Control
Mukkala, A. N., Jerkic, M., Khan, Z., Szaszi, K., Kapus, A., & Rotstein, O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115788 · Cited by 45
Immunomodulatory role of mesenchymal stem cell therapy in liver fibrosis
Liu, P., Qian, Y., Liu, X., Zhu, X., Zhang, X., Lv, Y., & Xiang, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1096402 · Cited by 47
CC chemokines family in fibrosis and aging: From mechanisms to therapy
Lei, W., Jia, L., Wang, Z., Liang, Z., Zhao, A., Liu, Y., Tian, Y., Zhao, L., Chen, Y.-W., Shi, G.-Y., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101900 · Cited by 43
Stem Cell Therapies for Chronic Liver Diseases: Progress and Challenges
Li, T., Wang, Z.-R., Yao, W., Linghu, E., Wang, F., & Shi, L. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szac053 · Cited by 40
Self-citationYuan, H., Xu, R., Li, S., Zheng, M., Tong, Q., Xiang, M., & Zhang, Y. (2025) · MedComm · doi:10.1002/mco2.70121 · Cited by 48
Self-citationWang, H., Yao, W., Wang, Y., Dong, H., Dong, T., Zhou, W., Cui, L., Zhao, L., Zhang, Y., Shi, L., et al. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03494-2 · Cited by 28
The Potential Clinical Use of Stem/Progenitor Cells and Organoids in Liver Diseases
Nikokiraki, C., Psaraki, A., & Roubelakis, M. G. (2022) · Cells · doi:10.3390/cells11091410 · Cited by 32
Huai, Q., Zhu, C., Zhang, X., Dai, H., Li, X., & Wang, H. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01122-3 · Cited by 27
Xu, Y., Zhou, X., Wang, X., Jin, Y., Zhou, L., & Ye, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116848 · Cited by 29
Placenta‐Derived Mesenchymal Stem Cells for Treatment of Diseases: A Clinically Relevant Source
Moonshi, S. S., Adelnia, H., Wu, Y., & Ta, H. T. (2022) · Advanced Therapeutics · doi:10.1002/adtp.202200054 · Cited by 30
Yao, W., Shi, L., Zhang, Y., Dong, H., & Zhang, Y. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02810-6 · Cited by 24
Liu, P., An, Y., Zhu, T., Tang, S., Huang, X., Li, S., Fu, F., Ji, C., & Xuan, K. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1131218 · Cited by 26
Tang, Y., Wu, P., Li, L., Xu, W., & Jiang, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.880523 · Cited by 23
Sadiq, I. Z., Abubakar, F. S., Katsayal, B. S., Ibrahim, B., Adamu, A., Usman, M. A., Aliyu, M., Suleiman, M. A., & Muhammad, A. (2025) · Biomedical Engineering Advances · doi:10.1016/j.bea.2025.100172 · Cited by 30
He, J., Du, C., Li, C., Li, W., Qiu, J., Ma, M., Chen, Y., & Zhang, Q. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103657 · Cited by 24
Selective targeting of endothelial and perivascular angiocrine ROCK2 treats liver fibrosis
Hu, Y., Yang, B., Xiao, C., Yang, X., Zhang, H., Yang, P., Du, X., Zhang, G., Liang, B., Bai, N., et al. (2026) · Cell · doi:10.1016/j.cell.2026.02.001 · Cited by 30
Elzainy, A., Sadik, A. E., & Altowayan, W. M. (2024) · Biomolecules · doi:10.3390/biom14030297 · Cited by 20
Yu, S., Kong, D., Lu, B., Pan, Y., Zeng, Z., Fu, Y., Zhao, Z., He, K., Tang, R., & Xia, Q. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04747-y · Cited by 23
Self-citationTherapeutic Targets and Approaches to Manage Inflammation of NAFLD
Geng, W., Liao, W., Cao, X., & Yang, Y. (2025) · Biomedicines · doi:10.3390/biomedicines13020393 · Cited by 20
Research progress in clinical trials of stem cell therapy for stroke and neurodegenerative diseases
Yan, S., de Souza, S. C., Xie, Z., & Bao, Y. (2023) · Ibrain · doi:10.1002/ibra.12095 · Cited by 18
The Crosstalk between Mesenchymal Stromal/Stem Cells and Hepatocytes in Homeostasis and under Stress
Kholodenko, I. V., Kholodenko, R. V., & Yarygin, K. N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015212 · Cited by 16
Advance of Mesenchymal Stem Cells in Chronic End-Stage Liver Disease Control
Gao, Y., Yin, X., & Ren, X. (2022) · Stem Cells International · doi:10.1155/2022/1526217 · Cited by 22
Fang, X., Gao, F., Yao, Q., Xu, H., Yu, J., Cao, H., & Li, S. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13030441 · Cited by 17
Chen, L., Huang, Y., Zhang, N., Qu, J., Fang, Y., Fu, J., Yuan, Y., Zhang, Q., Li, H., Wen, Z., et al. (2024) · MedComm · doi:10.1002/mco2.654 · Cited by 15
Self-citationShi, Q., Xia, Y., Wu, M., Pan, Y., Wu, S., Lin, J., Kong, Y., Yu, Z., Zan, X., Liu, P., et al. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.100958 · Cited by 14
A new era of gene and cell therapy for cancer: a narrative review
Wang, L., Liu, G., Zheng, L., Long, H., & Liu, Y. (2023) · Annals of Translational Medicine · doi:10.21037/atm-22-3882 · Cited by 16
Self-citationLi, H., Li, J., Wang, T., Sun, K., Huang, G., Cao, Y., Wu, F., & Xu, A. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.90441 · Cited by 19
Self-citationShi, X., Zhang, K., Qi, Q., Zhou, W., Yu, F., & Zhang, Y. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09664-6 · Cited by 13
Cell therapy for end-stage liver disease: Current state and clinical challenge
Zhang, L., Deng, Y., Bai, X., Wei, X., Ren, Y., Chen, S., & Deng, H. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003332 · Cited by 12
“[131] Noteworthily, a recent systematic meta-analysis investigated the efficacy and safety of MSCs in treating liver cirrhosis.”
Liver cell therapies: cellular sources and grafting strategies
Zhang, W., Cui, Y., Du, Y., Yang, Y., Fang, T., Lu, F., Kong, W.-X., Xiao, C., Shi, J., Reid, L. M., et al. (2023) · Frontiers of Medicine · doi:10.1007/s11684-023-1002-1 · Cited by 12
Wang, W., Lian, H., Liang, Y., Ye, Y., Tam, P. K. H., & Chen, Y. (2024) · Cells · doi:10.3390/cells13231997 · Cited by 13
Chen, L., Zhang, N., Huang, Y., Zhang, Q., Fang, Y., Fu, J., Yuan, Y., Chen, L., Chen, X., Xu, Z., et al. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10583-5 · Cited by 12
Self-citationThe revolutionary role of placental derivatives in biomedical research
Moghassemi, S., Nikanfar, S., Dadashzadeh, A., Sousa, M. J., Wan, Y., Sun, F., Colson, A., Windt, S. D., Kwaspen, L., Kanbar, M., et al. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.03.011 · Cited by 22
Self-citationYang, H. Y., Chen, J., & Li, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1243220 · Cited by 15
Shahrbaf, M. A., Nouri, M., Zarrabi, M., Gramignoli, R., & Vosough, M. (2022) · Cells · doi:10.3390/cells11071074 · Cited by 11
Wang, Z., Yao, L., Hu, X., Yuan, M., Chen, P., Liu, P., Zhang, Q., Xiong, Z., Dai, K., & Jiang, Y. (2023) · Tissue and Cell · doi:10.1016/j.tice.2023.102198 · Cited by 12
Pretreatment of UC-MSCs with IFN-α2 improves treatment of liver fibrosis by recruiting neutrophils
Xie, Y., Yao, J., Yan, M., Lin, Y., Wei, J., Wang, H., Mao, Y., Liu, P., & Li, X. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04732-0 · Cited by 9
Current state of stem cell research in non-human primates: an overview
Wu, J., Shi, Y., Yang, S., Tang, Z., Li, Z., Li, Z., Zuo, J., Ji, W., & Niu, Y. (2023) · Medical Review · doi:10.1515/mr-2023-0035 · Cited by 11
Ding, L., Huang, J., & Huang, S.-W. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2445283 · Cited by 11
Innovative Strategies in the Diagnosis and Treatment of Liver Cirrhosis and Associated Syndromes
Sah, A. K., Afzal, M., Elshaikh, R. H., Abbas, A. M., Shalabi, M. G., Prabhakar, P. K., Babker, A. M. A., Khalimova, F., Sabrievna, V. A., & Choudhary, R. K. (2025) · Life · doi:10.3390/life15050779 · Cited by 22
Choi, S., & Jeong, J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020619 · Cited by 12
Yao, Y., Zhang, L., Cheng, F., Jiang, Q., Ye, Y., Ren, Y., He, Y., Su, D., Cheng, L., Shi, G., et al. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03416-2 · Cited by 8
Xu, Y., Wang, X.-S., Zhou, X.-L., Lu, W.-M., Tang, X.-K., Jin, Y., & Ye, J.-S. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i32.3766 · Cited by 7
Tian, S., Zhou, X., Zheng, L., Liu, J., Zhang, M., Ma, S., Zheng, X., Guo, G., Ju, R., Yang, F., et al. (2025) · Biomaterials Research · doi:10.34133/bmr.0244 · Cited by 10
Luo, X., Deng, J., Jiang, X., Mi, J., Bai, Y., Zhang, H., Li, Y., Liu, M., Cai, C., Li, P., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70452 · Cited by 9
Self-citationNative and engineered extracellular vesicles: novel tools for treating liver disease
Jiang, S., Tian, S., Wang, P., Liu, J., Sun, K., Zhou, X., Han, Y., & Shang, Y. (2024) · Journal of Materials Chemistry B · doi:10.1039/d3tb01921g · Cited by 8
Ji, G., Zhang, Z., Wang, X., Guo, Q., Zhang, E., & Li, C. (2024) · Scientific Reports · doi:10.1038/s41598-024-70281-1 · Cited by 6
Thanh, L. N., Nguyen, H.-P., Kieu, T. P. T., Duy, M. N., Ha, H. T. T., Thi, H. B., Nguyen, T. Q., Pham, H. D., & Tran, T. D. (2024) · BMC Surgery · doi:10.1186/s12893-024-02669-9 · Cited by 6
Macrophage cytotherapy on liver cirrhosis
Ping, D., Peng, Y., Hu, X., & Liu, C. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1265935 · Cited by 6
Human Umbilical Cord Mesenchymal Stem Cells' Cultivation and Treatment of Liver Diseases
Zhu, Z., Zhang, Q., Liu, L., & Xu, J. (2022) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x17666220623111406 · Cited by 6
Cuadra, B., Silva, V., Huang, Y.-L., Díaz, Y., Rivas, C., Molina, C., Simon, V., Bono, M. R., Morales, B., Rosemblatt, M. S., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042073 · Cited by 7
He, A., Huang, Z., Feng, Q., Zhang, S., Li, F., Li, D., Lu, H., & Wang, J. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05576-y · Cited by 5
Hao, X., Zhu, H., Qin, C., Li, L., Lin, Z., Jiang, H., Li, Q., Huo, Y., Zhang, H., Geng, X., et al. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10780-w · Cited by 5
Li, W., Shi, X., Zhang, D., Hu, J., Zhao, S., Ye, S., Wang, J., Liu, X., Zhang, Q., Wang, Z., et al. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb00275c · Cited by 5
Self-citationQin, S., Bo, X., Liu, H., Zhang, Z., Zhao, Z., & Xia, Q. (2025) · Hepatology · doi:10.1097/hep.0000000000001321 · Cited by 8
Li, L., Si, Y., Cheng, M., Lang, L., Li, A., & Liu, B. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11570 · Cited by 4
He, K., Zhu, X., Shi, Y.-P., Huang, W., Yang, T., Xi, Z., Li, Q., Sun, H., Qian, L., Chen, X., et al. (2025) · Cell Discovery · doi:10.1038/s41421-025-00831-y · Cited by 6
Xie, Y., Li, Y., Yao, J., Song, X., Wang, H., Zhang, J., & Li, X. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45100532 · Cited by 4
Self-citationStem cells therapies for liver diseases: for current practice and future goals
Xie, Y., Zhang, Z., Pan, Y., & Wang, F. (2025) · Hepatology International · doi:10.1007/s12072-025-10835-1 · Cited by 7
Self-citationXie, D., Yu, L., Wang, Z., Qiu, G., & Ouyang, S. (2025) · Human Cell · doi:10.1007/s13577-025-01248-1 · Cited by 4
Wilujeng, I. D. A., Pramono, A. P., Tjang, Y. S., & Puspita, R. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10923-3 · Cited by 4
Mesenchymal stem cell therapy for end-stage liver disease: adversity and opportunity
Li, S., Wang, Y., Li, S., Zhu, Y., Du, Y., Zheng, X., & Wu, J. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04788-3 · Cited by 6
Extracellular Vesicles and Cellular Ageing
Romero-García, N., Mas‐Bargues, C., Huete-Acevedo, J., & Borrás, C. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-21410-3_11 · Cited by 6
Human Liver MSCs Retain Their Basic Cellular Properties in Chronically Inflamed Liver Tissue
Kim, Y. S., Lupatov, A. Y., Burunova, V. V., Bagmet, N. N., Chardarov, N. K., Malov, S. L., Kholodenko, R. V., Шатверян, Г. А., Manukyan, G. V., Yarygin, K. N., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413374 · Cited by 4
Chin, S. P., Ng, W.-C., Tai, L., Mohd, M. A., Then, K. Y., & Cheong, S. K. (2025) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-025-00384-2 · Cited by 5
Cellular therapies in liver and pancreatic diseases
Giuli, L., Santopaolo, F., Pallozzi, M., Pellegrino, A., Coppola, G., Gasbarrini, A., & Ponziani, F. R. (2022) · Digestive and Liver Disease · doi:10.1016/j.dld.2022.11.013 · Cited by 4
Interaction of Pulp and Periodontal Ligament in Treatment of Trauma
Futenma, T., Hayashi, Y., Iida, N., Nakamura, K., Sakatoku, S., & Nawa, H. (2023) · Journal of Hard Tissue Biology · doi:10.2485/jhtb.32.231 · Cited by 4
Wang, Z., Li, T., Zhang, Z., Yuan, M., Shi, M., Wang, F., Linghu, E., & Shi, L. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-078362 · Cited by 6
Self-citationModular mastery of inflammation: umbilical cord mesenchymal stem cells as a therapeutic frontier
Li, Y., Sun, C.-Y., Chen, G.-L., Xiang, Z., Hu, B., Zhou, F., & Wang, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1721947 · Cited by 6
Self-citationHuang, Y., Cheng, R., Wang, G., Xu, Z., Liu, S., Wan, Y., Hou, X., & Wang, J. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2025.1677021 · Cited by 4
Li, X., Zhang, F., Sun, L., Cai, X., Lou, F., Sun, Y., Gao, M., Wang, Z., Tang, S., Li, F., et al. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300752 · Cited by 3
Jin, L., Ren, C., Li, Y., Zhu, Y., Li, G., Chang, Y. S., Du, J., Yang, Z., & Yuan, Y. (2024) · Current Stem Cell Research & Therapy · doi:10.2174/011574888x287937240424074937 · Cited by 3
Self-citationGantier, M., Ménoret, S., Fourrier, A., Delbos, F., Nguyen, T. H., & Anegon, I. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1507317 · Cited by 3
Safety of intravenous mesenchymal stem cell therapy: a meta-analysis of randomized controlled trials
Habiba, U. E., Greene, D. L., Ahmad, K., Shamim, S., Khan, N., & Umer, A. (2025) · Regenerative medicine reports . · doi:10.4103/regenmed.regenmed-d-25-00006 · Cited by 7
Pan, X., Gao, T., & Wang, B. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01520-9 · Cited by 2
“Considering the study design, we deemed a randomized controlled, Phase II trial on HBV-related DLC to be the most compelling, featuring the largest sample size (219 patients) and the longest follow-up period (75 months) reported to date [287].”
Zhou, G. F., You, Y., Wang, B., Wang, S., Feng, T., Lai, C., Xiang, G., Yang, K. Q., & Yao, Y. (2024) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szae081 · Cited by 2
Mesenchymal Stem Cells in Liver Fibrosis: A Dose-Dependent Recovery
Lyundup, A. V., Shagidulin, M. Y., Онищенко, Н. А., Beregovykh, V. V., Крашенинников, М. Е., Venediktov, A. A., Pokidova, K., Nikolskaya, A. O., Kuzmin, E. A., Kostin, A. A., et al. (2025) · Applied Sciences · doi:10.3390/app151910471 · Cited by 2
Qin, X., Chen, J., Zhang, H.-N., Du, L., Ma, Y., Li, Y., Yu, L., Wang, Y., Wu, L.-F., Yu, Z., et al. (2025) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v17.i9.109980 · Cited by 3
Self-citationApplication of stem cells in the precise diagnosis and treatment of liver diseases
Wang, Y.-X., Ren, Y.-N., Zhang, S.-S., Sun, S., Xu, M.-Y., Wei, T., & Zhang, L.-S. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i46.114415 · Cited by 2
Costa, M. H. G., Terrasso, A. P., Crespo, I., Valero, R., Menéndez, B., Painho, B., Sousa, C. D., Gamelas, B., Tomás, H. A., Mancheño‐Corvo, P., et al. (2026) · BMC Biotechnology · doi:10.1186/s12896-026-01101-9 · Cited by 2
Hum, C., Poliwoda, J., Lalu, M. M., Stewart, D. J., Mei, S. H. J., Walley, K. R., Marshall, J., Mendelson, A. A., Fergusson, D. A., English, S. W., et al. (2026) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szag029 · Cited by 2
Song, Y., Lu, Z., Shu, W., Xiang, Z., Wang, Z., Wei, X., & Xu, X. (2023) · Cell Insight · doi:10.1016/j.cellin.2023.100115 · Cited by 2
Huang, S., Xu, X., Guo, J., Li, Z., Wu, Y., Liu, Y., Sun, Q., Wang, S., Yan, H., Su, Y., et al. (2025) · Journal of Cellular Physiology · doi:10.1002/jcp.70004 · Cited by 2
Therapeutic effect of hUC-MSCs from different transplantation routes on acute liver failure in rats
Wang, Y., Wu, B., Tao, Y.-C., Wang, M.-L., Wu, D., Chen, E., & Tang, H. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1525719 · Cited by 3
Nguyen, T. L., Nguyen, H.-P., Bui, T. H., Phan, T. K. T., Ngo, D. M., Thu, H. H. T., Tran, T. T., Luu, N. A. T., Phan, T. K., & Duy, H. P. (2025) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2025.162624 · Cited by 3
Tian, S., Guo, G., Zhou, X., Liu, Y., Jia, G., Zheng, L., Cui, L., Wang, K., Zhang, M., Sun, K., et al. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03622-y · Cited by 1
Shabunin, A. V., Владимирович, Б. В., Левина, О. Н., Drozdov, P. A., Tsurkan, V. A., Лиджиева, Э. А., Astapovich, S. А., & Ongoev, N. A. (2025) · Annaly khirurgicheskoy gepatologii = Annals of HPB surgery · doi:10.16931/1995-5464.2025-1-11-19 · Cited by 1
Metadata
- Authors
- Shi, M., Li, Y.-Y., Xu, R.-N., Meng, F.-P., Yu, S.-J., Fu, J.-L., Hu, J.-H., Li, J.-X., Wang, L.-F., Jin, L., & Wang, F.-S.
- Affiliations
- Chinese PLA General Hospital (CN)
- Corresponding author
- Shi, Ming
- Wang, Fu-Sheng
- Venue
- Hepatology International
- Published
- 2021-11-29
- Volume
- 15
- Issue
- 6
- Pages
- 1431-1441
- ISSN
- 1936-0533 (ISSN-L)
- 1936-0541
- PMC
- PMC8651584
- OpenAlex
- W3166597897
- Cited by
- 151
- References
- 32
- Citations by year
- 2026: 25 · 2025: 39 · 2024: 35 · 2023: 35 · 2022: 17
- FWCI
- 12.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Hepatology International (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- the National Key R&D Program of China (2017YFA0105703)
- National Natural Science Foundation of China (82070617)
- Innovative Research Group Project of the National Natural Science Foundation of China (81721002)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- mesenchymal stem cells, umbilical cord-derived stem cells, decompensated cirrhosis, HBV-related liver cirrhosis, stem cell therapy, overall survival, liver function, long-term follow-up, treatment safety
- MeSH terms
- Follow-Up Studies, Humans, Liver Cirrhosis, Prospective Studies, Treatment Outcome, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.